4//SEC Filing
Dalgarno David 4
Accession 0000899243-22-007499
CIK 0001745020other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:00 PM ET
Size
5.4 KB
Accession
0000899243-22-007499
Insider Transaction Report
Form 4
Dalgarno David
Chief Technical Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-18+130,000→ 130,000 totalExercise: $11.21Exp: 2032-02-17→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 25% of the options vesting on February 18, 2023 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.
Documents
Issuer
Theseus Pharmaceuticals, Inc.
CIK 0001745020
Entity typeother
Related Parties
1- filerCIK 0001876564
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:00 PM ET
- Size
- 5.4 KB